A003850 Stock Overview
Engages in the manufacture and sale of pharmaceutical products in South Korea and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
No risks detected for A003850 from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Boryung Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩10,440.00 |
| 52 Week High | ₩13,750.00 |
| 52 Week Low | ₩9,180.00 |
| Beta | 0.62 |
| 1 Month Change | 3.37% |
| 3 Month Change | -5.69% |
| 1 Year Change | -11.75% |
| 3 Year Change | -29.22% |
| 5 Year Change | -17.00% |
| Change since IPO | 1,626.95% |
Recent News & Updates
We Think Boryung (KRX:003850) Is Taking Some Risk With Its Debt
Sep 20
Earnings Not Telling The Story For Boryung Corporation (KRX:003850)
Aug 05Why We're Not Concerned About Boryung Corporation's (KRX:003850) Share Price
Apr 06Recent updates
We Think Boryung (KRX:003850) Is Taking Some Risk With Its Debt
Sep 20Earnings Not Telling The Story For Boryung Corporation (KRX:003850)
Aug 05Why We're Not Concerned About Boryung Corporation's (KRX:003850) Share Price
Apr 06A Look At The Fair Value Of Boryung Pharmaceutical Co., Ltd. (KRX:003850)
Apr 28Boryung Pharmaceutical (KRX:003850) Has A Pretty Healthy Balance Sheet
Mar 17Here's How We Evaluate Boryung Pharmaceutical Co., Ltd.'s (KRX:003850) Dividend
Feb 27Is Boryung Pharmaceutical Co., Ltd.'s (KRX:003850) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Feb 09Do Institutions Own Boryung Pharmaceutical Co., Ltd. (KRX:003850) Shares?
Jan 25Should You Use Boryung Pharmaceutical's (KRX:003850) Statutory Earnings To Analyse It?
Jan 10
If You Had Bought Boryung Pharmaceutical (KRX:003850) Shares Three Years Ago You'd Have Earned 122% Returns
Dec 23Is Boryung Pharmaceutical (KRX:003850) A Risky Investment?
Dec 08Would Boryung Pharmaceutical Co., Ltd. (KRX:003850) Be Valuable To Income Investors?
Nov 23Shareholder Returns
| A003850 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | -1.7% | 1.0% | -0.9% |
| 1Y | -11.7% | 2.4% | -9.0% |
Return vs Industry: A003850 underperformed the KR Pharmaceuticals industry which returned 2.4% over the past year.
Return vs Market: A003850 underperformed the KR Market which returned -9% over the past year.
Price Volatility
| A003850 volatility | |
|---|---|
| A003850 Average Weekly Movement | 5.2% |
| Pharmaceuticals Industry Average Movement | 5.6% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in KR Market | 12.7% |
| 10% least volatile stocks in KR Market | 3.3% |
Stable Share Price: A003850 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A003850's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1957 | n/a | Jay Kim | www.boryung.co.kr |
Boryung Corporation engages in the manufacture and sale of pharmaceutical products in South Korea and internationally. It offers prescription drugs for hypertension, dyslipidemia, diabetes, central nervous system, and oncology drugs. The company was formerly known as Boryung Pharmaceutical Co., Ltd.
Boryung Corporation Fundamentals Summary
| A003850 fundamental statistics | |
|---|---|
| Market cap | ₩687.64b |
| Earnings (TTM) | ₩62.00b |
| Revenue (TTM) | ₩991.43b |
11.1x
P/E Ratio0.7x
P/S RatioIs A003850 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A003850 income statement (TTM) | |
|---|---|
| Revenue | ₩991.43b |
| Cost of Revenue | ₩613.73b |
| Gross Profit | ₩377.70b |
| Other Expenses | ₩315.70b |
| Earnings | ₩62.00b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 941.24 |
| Gross Margin | 38.10% |
| Net Profit Margin | 6.25% |
| Debt/Equity Ratio | 30.4% |
How did A003850 perform over the long term?
See historical performance and comparisonDividends
1.0%
Current Dividend Yield11%
Payout RatioDoes A003850 pay a reliable dividends?
See A003850 dividend history and benchmarks| Boryung dividend dates | |
|---|---|
| Ex Dividend Date | Dec 27 2024 |
| Dividend Pay Date | Apr 25 2025 |
| Days until Ex dividend | 1 day |
| Days until Dividend pay date | 120 days |
Does A003850 pay a reliable dividends?
See A003850 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/25 19:40 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Boryung Corporation is covered by 10 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hyung Soo Kim | Cape Investment & Securities Co., Ltd. |
| Myung Sun Lee | DB Financial Investment Co. Ltd. |
| Hyung Soo Kim | Hanwha Investment & Securities Co., Ltd. |